All Journals > Infection Control and Hospital Epidemiology > April 2007 > Surveillance System for MRSA in German Hospitals

Article Tools

Search for Related Articles

  • By Author
  • Search In

Highlighted Article

NHSN Annual Update:
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections

Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

Antimicrobial-resistant pathogens that cause healthcare-associated infections (HAIs) pose an ongoing and increasing challenge to hospitals, both in the clinical treatment of patients and in the prevention of the cross-transmission of these problematic pathogens.  Describing the magnitude of the problem with respect to these antimicrobial-resistant pathogens is challenging, because the levels of antimicrobial resistance vary for different types of healthcare facilities and for different geographic areas, and some resistance phenotypes are difficult for laboratories to detect. However, the findings from such attempts may help the infection control and public health communities target problems and utilize resources more efficiently.

In the News

Featured in The Times
"Ireland 'losing war' on superbug" February 15, 2009
Challenges of Implementing National Guidelines for the Control and Prevention of Methicillin‐Resistant Staphylococcus aureus Colonization or Infection in Acute Care Hospitals in the Republic of Ireland
Fidelma Fitzpatrick, MD; Fiona Roche, PhD; Robert Cunney, MB; Hilary Humphreys, MD; Strategy for the Control of Antimicrobial Resistance in Ireland Infection Control Subcommittee
The research, published in Infection Control and Hospital Epidemiology, found one third of hospitals did not have a written policy on antibiotic use, and only 35% had an antibiotic stewardship programme.

April 2007

Volume 28, Number 4
Infect Control Hosp Epidemiol 2007;28:446–452
0899-823X/2007/2804-0013$15.00
DOI: 10.1086/513444
Original Article

Development of a Surveillance System for Methicillin‐Resistant Staphylococcus aureus in German Hospitals

Iris F. Chaberny, MD;

Dorit Sohr, PhD;

Henning Rüden, MD;

Petra Gastmeier, MD

From the Institute of Medical Microbiology and Hospital Epidemiology, Medical School Hannover (I.F.C., P.G.), the Institute of Hygiene and Environmental Medicine, Charité‐University Medicine, Free University and Humboldt University Berlin (D.S., H.R.), and the German National Reference Center for Surveillance of Nosocomial Infections (I.F.C., D.S., H.R., P.G.), Germany.

Objective.To determine the appropriate method to calculate the rate of methicillin‐resistant Staphylococcus aureus (MRSA) infection and colonization (hereafter, MRSA rates) for interhospital comparisons, such that the large number of patients who are already MRSA positive on admission is taken into account.

Design.A prospective, multicenter, hospital‐based surveillance of MRSA‐positive case patients from January through December 2004.

Setting.Data from 31 hospitals participating in the German national nosocomial infections surveillance system (KISS) were recorded during routine surveillance by the infection control team at each hospital.

Results.Data for 4,215 MRSA‐positive case patients were evaluated. From this data, the following values were calculated. The median incidence density was 0.71 MRSA‐positive case patients per 1,000 patient‐days, and the median nosocomial incidence density was 0.27 patients with nosocomial MRSA infection or colonization per 1,000 patient‐days (95% CI, 0.18‐0.34). The median average daily MRSA burden was 1.13 MRSA patient‐days per 100 patient‐days (95% CI, 0.86‐1.51), with the average daily MRSA burden defined as the total number of MRSA patient‐days divided by the total number of patient‐days times 100. The median MRSA‐days–associated nosocomial MRSA infection and colonization rate, which describes the MRSA infection risk for other patients in hospitals housing large numbers of MRSA‐positive patients and/or many patients who were MRSA positive on admission, was 23.1 cases of nosocomial MRSA infection and colonization per 1,000 MRSA patient‐days (95% CI, 17.4‐28.6). The values were also calculated for various MRSA screening levels.

Conclusions.The MRSA‐days–associated nosocomial MRSA rate allows investigators to assess the extent of MRSA colonization and infection at each hospital, taking into account cases that have been imported from other hospitals, as well as from the community. This information provides an appropriate incentive for hospitals to introduce further infection control measures.

Received February 5, 2006; accepted July 6, 2006; electronically published March 15, 2007.

Address reprint requests to Iris F. Chaberny, MD, Medical School Hannover, Institute of Medical Microbiology and Hospital Epidemiology, Carl‐Neuberg‐Str. 1, D‐30625 Hannover, ().

Cited by

Todd C. Lee, MD; Christine Moore, ART; Janet M. Raboud, PhD; Matthew P. Muller, MD, PhD; Karen Green, MSc; Agnes Tong, MSc; Jastej Dhaliwal, MSc; Allison McGeer, MD; Mount Sinai Hospital Infection Control Team. (2009) Impact of a Mandatory Infection Control Education Program on Nosocomial Acquisition of Methicillin‐Resistant Staphylococcus aureus •. Infection Control and Hospital Epidemiology 30:3, 249-256
Online publication date: 1-Mar-2009.
Elisabeth Meyer, MD; Andreas Conrad, MD; Christian Schneider, MD; Annerose Serr, MD; Regina Babikir; Markus Dettenkofer, MD, PhD. (2008) Burden of Imported Cases of Infection or Colonization With Multidrug‐Resistant Organisms in a German University Hospital •. Infection Control and Hospital Epidemiology 29:12, 1195-1196
Online publication date: 1-Dec-2008.
I. F. Chaberny, F. Schwab, S. Ziesing, S. Suerbaum, P. Gastmeier. (2008) Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted time-series analysis. Journal of Antimicrobial Chemotherapy 62:6, 1422-1429
Online publication date: 10-Oct-2008.
CrossRef
Adam L. Cohen, MD, MPH; David Calfee, MD, MS; Scott K. Fridkin, MD; Susan S. Huang, MD, MPH; John A. Jernigan, MD; Ebbing Lautenbach, MD, MPH, MSCE; Shannon Oriola, RN, CIC, COHN; Keith M. Ramsey, MD; Cassandra D. Salgado, MD, MS; Robert A. Weinstein, MD; Society for Healthcare Epidemiology of America and the Healthcare Infection Control Practices Advisory Committee. (2008) Recommendations for Metrics for Multidrug‐Resistant Organisms in Healthcare Settings: SHEA/HICPAC Position Paper •. Infection Control and Hospital Epidemiology 29:10, 901-913
Online publication date: 1-Oct-2008.
Close Popup